Truncated Insect Aspartate Decarboxylases for Beta-Alanine Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Industrial-scale biological synthesis of beta-alanine is hindered by enzymes with poor activity, expression, and/or stability, making chemical synthesis more viable, despite its safety and environmental concerns.

Innovation Solution

Development of recombinant truncated insect aspartate 1-decarboxylase (ADC) enzymes, specifically truncated variants of insect ADCs, which exhibit increased conversion of aspartate to beta-alanine, improved stability, and enhanced expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If full-length wild-type insect ADC is used, then enzyme structure is complete, but catalytic activity and stability are poor

Engineering Contradiction:
Improvecatalytic activityVSAvoidenzyme structure
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The ADC enzyme is divided into functional segments: the N-terminal region (residues 1-71) is removed as a separate segment that hinders activity, while the C-terminal catalytic region (residues 72-561) is retained as the functional segment. This segmentation isolates the harmful N-terminal portion from the beneficial catalytic core, resolving the contradiction between complete structure and high activity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The N-terminal region (residues 1-71) is extracted and removed from the full-length ADC sequence. This extraction eliminates the portion that causes poor stability and expression while preserving the essential catalytic function in the remaining C-terminal region, thereby improving productivity without compromising essential enzyme function.

Inventive Principle:
Principle #2Taking out (Extraction)

2Reliability

If full-length wild-type insect ADC is used, then complete amino acid sequence is present, but expression and stability are poor

Engineering Contradiction:
Improveenzyme stabilityVSAvoidamino acid sequence
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The unstable N-terminal region (residues 1-71) is extracted and removed from the enzyme sequence. This extraction eliminates the source of instability and poor expression while retaining the stable catalytic core (residues 72-561), thereby improving reliability without removing essential functional elements.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Different regions of the enzyme are assigned different functional qualities: the N-terminal region is identified as having poor stability and expression properties, while the C-terminal region possesses the desired catalytic activity and stability. By modifying only the problematic N-terminal region through truncation while preserving the high-quality C-terminal catalytic domain, the enzyme achieves improved overall stability.

Inventive Principle:
Principle #3Local quality

3Productivity

If chemical synthesis process is used, then production scale is achievable, but safety and environmental issues arise

Engineering Contradiction:
Improveproduction scaleVSAvoidsafety and environmental impact
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The production method undergoes a fundamental parameter change from chemical synthesis to biological catalysis. The truncated ADC enzyme enables biological production to achieve industrial scalability by dramatically improving catalytic activity and stability, allowing the process to operate under milder, safer conditions while maintaining productivity comparable to chemical methods. This parameter change eliminates harmful chemical reagents and conditions while preserving large-scale production capability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The truncated insect ADCs demonstrate significantly higher catalytic activity and stability, facilitating efficient biological production of beta-alanine on a commercial scale.

Implementation Method 1

recombinant truncated insect aspartate 1-decarboxylase (ADC)... exhibit increased conversion of aspartate to beta-alanine

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

aspartate 1-decarboxylase... catalyze the conversion of the aspartate to beta-alanine

Methodology Applied
Scientific EffectDecarboxylation: Decomposition (biological)

Data Source

PatentUS20250277204A1Insect-derived aspartate decarboxylases and variants thereof for improved beta-alanine production
Publication Date: 2025.09.04 MOJIA BIOTECH LTD
  • US20250277204A1 patent drawing
  • US20250277204A1 patent drawing
  • US20250277204A1 patent drawing

AI summary

Provided are N-terminally truncated variants of insect aspartate 1-decarboxylases that exhibit improved performance for beta-alanine production.